Plasmolipin regulates basolateral-to-apical transcytosis of ICAM-1 and leukocyte adhesion in polarized hepatic epithelial cells.
Cell Adhesion
/ physiology
Cell Line, Tumor
Epithelial Cells
/ metabolism
Hep G2 Cells
Hepatocytes
/ metabolism
Humans
Intercellular Adhesion Molecule-1
/ metabolism
Liver
/ metabolism
Myelin and Lymphocyte-Associated Proteolipid Proteins
/ genetics
T-Lymphocytes
/ metabolism
Transcytosis
/ physiology
Apicobasal polarity
BioID
Hepatocyte
ICAM-1
Lymphocyte adhesion
PLLP
Subapical compartment, bile canaliculus
Transcytosis
Journal
Cellular and molecular life sciences : CMLS
ISSN: 1420-9071
Titre abrégé: Cell Mol Life Sci
Pays: Switzerland
ID NLM: 9705402
Informations de publication
Date de publication:
09 Jan 2022
09 Jan 2022
Historique:
received:
27
04
2021
accepted:
03
12
2021
revised:
02
12
2021
entrez:
9
1
2022
pubmed:
10
1
2022
medline:
19
1
2022
Statut:
epublish
Résumé
Apical localization of Intercellular Adhesion Receptor (ICAM)-1 regulates the adhesion and guidance of leukocytes across polarized epithelial barriers. Here, we investigate the molecular mechanisms that determine ICAM-1 localization into apical membrane domains of polarized hepatic epithelial cells, and their effect on lymphocyte-hepatic epithelial cell interaction. We had previously shown that segregation of ICAM-1 into apical membrane domains, which form bile canaliculi and bile ducts in hepatic epithelial cells, requires basolateral-to-apical transcytosis. Searching for protein machinery potentially involved in ICAM-1 polarization we found that the SNARE-associated protein plasmolipin (PLLP) is expressed in the subapical compartment of hepatic epithelial cells in vitro and in vivo. BioID analysis of ICAM-1 revealed proximal interaction between this adhesion receptor and PLLP. ICAM-1 colocalized and interacted with PLLP during the transcytosis of the receptor. PLLP gene editing and silencing increased the basolateral localization and reduced the apical confinement of ICAM-1 without affecting apicobasal polarity of hepatic epithelial cells, indicating that ICAM-1 transcytosis is specifically impaired in the absence of PLLP. Importantly, PLLP depletion was sufficient to increase T-cell adhesion to hepatic epithelial cells. Such an increase depended on the epithelial cell polarity and ICAM-1 expression, showing that the epithelial transcytotic machinery regulates the adhesion of lymphocytes to polarized epithelial cells. Our findings strongly suggest that the polarized intracellular transport of adhesion receptors constitutes a new regulatory layer of the epithelial inflammatory response.
Identifiants
pubmed: 34999972
doi: 10.1007/s00018-021-04095-z
pii: 10.1007/s00018-021-04095-z
pmc: PMC8743267
doi:
Substances chimiques
ICAM1 protein, human
0
Myelin and Lymphocyte-Associated Proteolipid Proteins
0
PLLP protein, human
0
Intercellular Adhesion Molecule-1
126547-89-5
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
61Subventions
Organisme : Agencia Estatal de Investigación
ID : SAF2017-88187
Organisme : Agencia Estatal de Investigación
ID : PID2020-119881RB-I00
Organisme : Comunidad de Madrid
ID : S2017/BMD-3817 TomoXliver
Informations de copyright
© 2022. The Author(s).
Références
Nucleic Acids Res. 2015 Aug 18;43(14):6787-98
pubmed: 26117540
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
Blood. 2002 Feb 1;99(3):978-84
pubmed: 11807002
J Biol Chem. 1997 Jul 18;272(29):18311-5
pubmed: 9218471
Cell Mol Life Sci. 2012 Sep;69(18):3079-99
pubmed: 22573182
Nat Protoc. 2007;2(10):2480-91
pubmed: 17947990
Nat Cell Biol. 2015 Mar;17(3):241-50
pubmed: 25706235
Mol Biol Cell. 2002 Jan;13(1):225-37
pubmed: 11809835
Mol Biol Cell. 2007 Oct;18(10):3978-92
pubmed: 17686995
J Cell Biol. 2016 May 9;213(3):385-402
pubmed: 27138256
Nat Cell Biol. 2006 Feb;8(2):113-23
pubmed: 16429128
J Cell Biol. 2017 Nov 6;216(11):3847-3859
pubmed: 28887437
Mucosal Immunol. 2014 Jul;7(4):905-15
pubmed: 24345805
Nature. 2011 Jun 29;475(7356):390-3
pubmed: 21716291
J Cell Sci. 2019 Oct 10;133(5):
pubmed: 31601617
Mol Med. 1996 Jul;2(4):489-505
pubmed: 8827719
Am J Pathol. 2019 Oct;189(10):1933-1944
pubmed: 31404540
Mol Biol Cell. 2008 Oct;19(10):4224-37
pubmed: 18685082
J Immunol. 1986 Aug 15;137(4):1270-4
pubmed: 3525675
Dev Cell. 2010 May 18;18(5):814-27
pubmed: 20493814
Trends Biochem Sci. 2002 Dec;27(12):599-601
pubmed: 12468223
Cell Mol Life Sci. 2019 Apr;76(7):1299-1317
pubmed: 30552441
Viruses. 2017 Apr 01;9(4):
pubmed: 28368306
Nat Rev Immunol. 2015 Nov;15(11):692-704
pubmed: 26471775
Dev Cell. 2006 Feb;10(2):223-32
pubmed: 16459301
Mol Biol Cell. 2013 Feb;24(4):483-94
pubmed: 23264465
J Exp Med. 2008 Dec 22;205(13):3201-13
pubmed: 19064697
J Leukoc Biol. 2020 Mar;107(3):393-408
pubmed: 31990103
J Cell Sci. 2004 May 1;117(Pt 11):2183-92
pubmed: 15126620
Mediators Inflamm. 2016;2016:7650260
pubmed: 26941485
Methods Mol Biol. 2003;228:223-30
pubmed: 12824556
J Drug Target. 2017 Nov - Dec;25(9-10):786-795
pubmed: 28665212
FASEB J. 2002 Aug;16(10):1257-9
pubmed: 12060669
Mol Syst Biol. 2016 Apr 04;12(4):862
pubmed: 27044256
Nat Cell Biol. 2020 Feb;22(2):213-224
pubmed: 31988382
J Cell Sci. 2011 Aug 1;124(Pt 15):2529-38
pubmed: 21750196
J Cell Biol. 2002 Oct 14;159(1):37-44
pubmed: 12370246
Science. 2005 Dec 2;310(5753):1492-5
pubmed: 16282525
J Cell Biol. 2012 Mar 19;196(6):801-10
pubmed: 22412018
Eur J Immunol. 1998 Nov;28(11):3675-84
pubmed: 9842910
J Neurochem. 2003 Jul;86(2):508-18
pubmed: 12871592
Mol Biol Cell. 2009 Aug;20(16):3751-62
pubmed: 19553470
J Cell Biol. 1996 Nov;135(4):913-24
pubmed: 8922376
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
Nat Rev Immunol. 2006 Dec;6(12):919-29
pubmed: 17124513
J Cell Biol. 1997 Apr 21;137(2):347-57
pubmed: 9128247
J Cell Sci. 2001 Nov;114(Pt 22):3957-65
pubmed: 11739628
J Cell Sci. 2015 Jul 1;128(13):2293-302
pubmed: 26002055
Cell Rep. 2014 Sep 25;8(6):1879-1893
pubmed: 25242329